Mettler-Toledo International, Inc. (NYSE:MTD) Shares Sold by Diversified Trust Co

Diversified Trust Co decreased its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 23.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,133 shares of the medical instruments supplier's stock after selling 347 shares during the quarter. Diversified Trust Co's holdings in Mettler-Toledo International were worth $1,338,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. SBI Securities Co. Ltd. bought a new stake in Mettler-Toledo International in the fourth quarter worth about $33,000. Edmond DE Rothschild Holding S.A. bought a new stake in shares of Mettler-Toledo International during the 4th quarter worth approximately $44,000. Golden State Wealth Management LLC boosted its holdings in Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after acquiring an additional 35 shares during the period. Whipplewood Advisors LLC bought a new position in Mettler-Toledo International in the 4th quarter valued at $54,000. Finally, Menard Financial Group LLC bought a new position in Mettler-Toledo International in the 4th quarter valued at $67,000. Institutional investors own 95.07% of the company's stock.

Insider Activity

In other news, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director owned 120 shares in the company, valued at $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.77% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

MTD has been the topic of a number of research reports. Barclays assumed coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 target price on the stock. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their price target for the company from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Bank of America upped their price target on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Finally, Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a report on Monday, April 7th. Eight research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International currently has an average rating of "Hold" and an average price target of $1,300.36.

Mettler-Toledo International Price Performance

MTD traded up $29.90 on Tuesday, reaching $1,204.62. 115,639 shares of the stock were exchanged, compared to its average volume of 150,273. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The firm has a market capitalization of $25.03 billion, a PE ratio of 30.04, a PEG ratio of 3.61 and a beta of 1.37. The company's 50-day moving average price is $1,138.07 and its 200 day moving average price is $1,196.50.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The company had revenue of $883.74 million for the quarter, compared to the consensus estimate of $876.61 million. During the same quarter in the prior year, the company earned $8.89 EPS. Mettler-Toledo International's quarterly revenue was down 4.6% on a year-over-year basis. As a group, equities analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.